Today: 14 June 2026

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Stock Market Today, Nov. 20, 2025: Nvidia Rally vs Fed Caution on FOMC Minutes, Trade Gap and Oil

WeShop (WSHP) Stock Today, 20 November 2025: U.S. App Launch, 500% Rally and Sharp Pre‑Market Selloff

WeShop Holdings’ U.S. social-commerce app launched 20 November as its Nasdaq-listed shares plunged up to 41% pre-market after a 506% surge to $200 the previous day. The stock, which debuted at $20.02 on 14 November, briefly touched $228 amid heavy volatility and repeated trading halts. Market cap estimates now range from $2.5 to $6.8 billion, despite trailing revenue under $2 million and steep losses.
20 November 2025
Stock Market Today, Nov. 20, 2025: Nvidia Rally vs Fed Caution on FOMC Minutes, Trade Gap and Oil

Stock Market Today, Nov. 20, 2025: Nvidia Rally vs Fed Caution on FOMC Minutes, Trade Gap and Oil

Nvidia beat earnings forecasts and raised its revenue outlook, sending U.S. stock futures sharply higher Thursday. FOMC minutes show many Fed officials oppose a December rate cut, citing stalled inflation progress. The U.S. August trade deficit narrowed 24% to $59.6 billion. EIA data show crude oil inventories fell by 3.4 million barrels last week.
Psyence BioMed (NASDAQ: PBM) Jumps as It Secures Pharmaceutical‑Grade Ibogaine Supply for Global Clinical Trials – 20 November 2025

Psyence BioMed (NASDAQ: PBM) Jumps as It Secures Pharmaceutical‑Grade Ibogaine Supply for Global Clinical Trials – 20 November 2025

Psyence BioMed (NASDAQ: PBM) secured a sustainable supply of pharmaceutical-grade ibogaine through PsyLabs, receiving an initial 50 kg shipment of high-potency iboga bark for processing. PBM shares rose 21.5% to $3.39 in pre-market trading Thursday, after being named among top healthcare movers.
Bath & Body Works (BBWI) Stock Hit by Q3 2025 Miss, Holiday Sales Warning and New ‘Consumer First’ Turnaround Plan

Bath & Body Works (BBWI) Stock Hit by Q3 2025 Miss, Holiday Sales Warning and New ‘Consumer First’ Turnaround Plan

Bath & Body Works shares fell sharply Thursday after the company missed third-quarter earnings estimates, cut its full-year forecast, and warned of weaker holiday demand. Net sales for Q3 dropped 1% to $1.594 billion, with net income falling to $77 million from $106 million a year ago. The stock traded near $21, down 46% year to date. The company now expects full-year sales to decline and EPS of at least $2.83.
ZIM Integrated Shipping Services (ZIM) Q3 2025 Earnings: Profit Slumps, Guidance Raised and Dividend Declared

ZIM Integrated Shipping Services (ZIM) Q3 2025 Earnings: Profit Slumps, Guidance Raised and Dividend Declared

ZIM Integrated Shipping reported Q3 2025 net income of $123 million, down nearly 90% from $1.13 billion a year earlier, as average freight rates fell 35%. Revenue dropped to $1.78 billion from $2.77 billion. The company raised its full-year outlook and declared a $0.31 per share dividend, sending shares and options trading higher. Operating cash flow for the quarter was $628 million.
Sonder Holdings (SOND) Bankruptcy Latest: Chapter 7 Liquidation, Lawsuits and Stock Outlook – 20 November 2025

Sonder Holdings (SOND) Bankruptcy Latest: Chapter 7 Liquidation, Lawsuits and Stock Outlook – 20 November 2025

Sonder Holdings filed for Chapter 7 bankruptcy in Delaware after Marriott ended a 20-year licensing deal, triggering an immediate wind-down and global insolvency proceedings. SOND shares traded at $0.09 on November 20, down from a $1.9 billion valuation in 2022. A WARN Act class action alleges 1,000 employees were laid off without proper notice. Industry estimates say nearly 10,000 units are affected worldwide.
Mobile-health Network Solutions (MNDR) Stock Surges on $120 Million AI Data Center Deal in Malaysia – November 20, 2025 Update

Mobile-health Network Solutions (MNDR) Stock Surges on $120 Million AI Data Center Deal in Malaysia – November 20, 2025 Update

Mobile-health Network Solutions said it will acquire two AI-optimized data centers in Malaysia for up to US$120 million, paying with 3 million Class A shares. The announcement sent MNDR shares sharply higher in pre-market trading Thursday. The deal, structured as a memorandum of understanding with PPG PP GRID SDN. BHD., remains subject to due diligence and approvals.
CoreWeave (CRWV) Stock News Today, November 20, 2025: Nvidia Q3 Beat Ignites Rebound After 50% Slide

CoreWeave (CRWV) Stock News Today, November 20, 2025: Nvidia Q3 Beat Ignites Rebound After 50% Slide

CoreWeave shares jumped nearly 10% in pre-market trading Thursday, rebounding to around $82 after Nvidia’s strong Q3 earnings triggered renewed interest in AI infrastructure stocks. The move follows a steep 50% drop from CoreWeave’s 52-week high, despite reporting Q3 revenue of $1.36 billion and a $55.6 billion backlog. The stock remains down 34.5% over the last 10 sessions amid concerns over guidance cuts and data-center delays.
Ray Dalio’s Bridgewater Dumps Nvidia, Backs Applied Materials as Hedge Funds Turn Away From the ‘Magnificent Seven’

Ray Dalio’s Bridgewater Dumps Nvidia, Backs Applied Materials as Hedge Funds Turn Away From the ‘Magnificent Seven’

Bridgewater Associates cut its Nvidia stake by nearly 65% and more than halved its Alphabet holdings in Q3, according to new 13F filings. The hedge fund increased positions in Applied Materials and software firms instead. Regulatory disclosures show other major funds also reducing exposure to the Magnificent Seven as U.S. markets approach record highs.
20 November 2025
Palo Alto Networks (PANW) News Today: Chronosphere Deal, Q1 Beat, VPN Attack Surge and AI Security Push – 20 November 2025

Palo Alto Networks (PANW) News Today: Chronosphere Deal, Q1 Beat, VPN Attack Surge and AI Security Push – 20 November 2025

Palo Alto Networks announced a $3.35 billion acquisition of Chronosphere and reported fiscal Q1 2026 revenue of $2.47 billion, beating estimates. Shares traded near $199.90, down slightly after a sharper drop post-earnings. The company faced over 2.3 million attacks on its GlobalProtect VPN portals. Wall Street reactions were mixed, with price targets ranging from $135 to $255.
20 November 2025
Broadcom (AVGO) Surges on Quantum‑Safe 128G AI Switch Launch, Nvidia Boost and VMware Licensing Fight – November 20, 2025

Broadcom (AVGO) Surges on Quantum‑Safe 128G AI Switch Launch, Nvidia Boost and VMware Licensing Fight – November 20, 2025

Broadcom shares rose 3% Thursday to around $354 after launching Brocade Gen 8 storage-networking products aimed at AI data centers. The stock is up over 110% in the past year, with a market cap near $1.7 trillion. Vanguard now holds 10.28% of shares, as institutional investors remain dominant. The new products offer 128G performance and quantum-safe encryption, with OEM partners set to ship solutions in coming quarters.
VOO vs QQQ, VOOG vs MGK and VOO’s $78 ‘Twin’: What ETF Investors Need to Know on November 20, 2025

VOO vs QQQ, VOOG vs MGK and VOO’s $78 ‘Twin’: What ETF Investors Need to Know on November 20, 2025

On November 20, 2025, new analysis from The Motley Fool and Nasdaq compared top ETFs VOO, QQQ, VOOG, MGK, and SPYM, focusing on fees, diversification, and concentration risk. VOO offers broad S&P 500 exposure at a 0.03% fee, while QQQ is tech-heavy with a 0.20% fee. SPYM tracks the S&P 500 at a lower price and 0.02% fee. Coverage highlights renewed debate over diversification versus concentration in index investing.
First Kiss Dates Back 21 Million Years, Study Finds Neanderthals Also Kissed

First Kiss Dates Back 21 Million Years, Study Finds Neanderthals Also Kissed

Kissing likely originated 16.9–21.5 million years ago in the common ancestor of great apes, according to a new study led by Matilda Brindle of Oxford. Researchers found kiss-like behavior in humans, chimpanzees, bonobos, orangutans, and some gorillas, but not in gibbons or most monkeys. The study estimates an 84% probability that Neanderthals also kissed. Findings appear in Evolution and Human Behavior.
20 November 2025
Abbott to Acquire Exact Sciences for $21 Billion in Cancer Screening Mega-Deal

Abbott to Acquire Exact Sciences for $21 Billion in Cancer Screening Mega-Deal

Abbott will acquire Exact Sciences for $105 per share in cash, valuing the deal at about $23 billion including debt. The boards of both companies approved the transaction, which is set to close in the second quarter of 2026 pending shareholder and regulatory approval. Exact Sciences will become a subsidiary, expanding Abbott’s diagnostics revenue and portfolio. The offer represents a 21–22% premium to Exact’s last closing price.
1 22 23 24 25 26 146

Stock Market Today

  • SpaceX Stock Surges Post-IPO but Faces Potential Decline
    June 13, 2026, 10:32 PM EDT. SpaceX (NASDAQ:SPCX) shares surged 19% on debut, pushing valuation past $2 trillion, defying analysts' expectations. However, short-seller Jim Chanos criticized the surge, citing the company's $4.2 billion Q1 loss and $18 billion projected 2025 revenue as valuation concerns. Further pressure may arise as hype fades and investors shift focus to upcoming AI IPOs like OpenAI and Anthropic. The firm's AI arm, xAI, contributed to sustained losses. Additionally, SpaceX's tiered 180-day lock-up expiry allows insiders to sell shares, potentially triggering a price decline. Analysts warn of increased volatility as insider selling approaches, suggesting a cautious outlook post-IPO for SPCX shares.

Latest articles

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

14 June 2026
Kraft Heinz closed up 0.70% at $24.39, outpacing the S&P 500, as investors weighed its 6.6% dividend yield against falling organic sales, lower adjusted earnings, and cautious analyst targets; the next earnings update is seen as the key test for whether $600 million in marketing and R&D can revive growth and support the stock’s rebound.
Go toTop